About BTG plc (LON:BTG)
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing. The Interventional Medicine segment includes oncology, vascular and pulmonology. The segment's products include Beads, TheraSphere, EkoSonic, Varithena and PneumRx Coils for use in the treatment of liver tumors, blood clots, varicose veins and advanced emphysema. The Specialty Pharmaceuticals segment includes CroFab, DigiFab, Voraxaze and Vistogard products for use in the treatment of crotalid envenomation, digoxin toxicity, high-dose methotrexate toxicity and 5-fluorouracil toxicity. The Licensing segment includes Zytiga, Two-Part Hip Cup and Lemtrada products for use in the treatment of advanced prostate cancer, hip replacement and multiple sclerosis.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Pharmaceuticals
- Sub-Industry: N/A
- Symbol: LON:BTG
- CUSIP: N/A
- Web: www.btgplc.com
- Market Cap: £2.85 billion
- Outstanding Shares: 385,095,000
- 50 Day Moving Avg: GBX 696.38
- 200 Day Moving Avg: GBX 675.29
- 52 Week Range: GBX 528.36 - GBX 764.58
Sales & Book Value:
- Trailing P/E Ratio: 86.05
- P/E Growth: 1.38
- Annual Revenue: £570.5 million
- Price / Sales: 5.00
- Book Value: GBX 2.55 per share
- Price / Book: 2.90
- EBITDA: £135.3 million
- Net Margins: 7.26%
- Return on Equity: 4.33%
- Return on Assets: 3.18%
- Average Volume: 499,084 shs.
Frequently Asked Questions for BTG plc (LON:BTG)
What is BTG plc's stock symbol?
BTG plc trades on the London Stock Exchange (LON) under the ticker symbol "BTG."
Where is BTG plc's stock going? Where will BTG plc's stock price be in 2017?
9 brokerages have issued twelve-month price targets for BTG plc's shares. Their forecasts range from GBX 680 to GBX 900. On average, they expect BTG plc's share price to reach GBX 780.33 in the next twelve months. View Analyst Ratings for BTG plc.
Who are some of BTG plc's key competitors?
Some companies that are related to BTG plc include Catalent (CTLT), Patheon NV (PTHN), Taro Pharmaceutical Industries (TARO), Valeant Pharmaceuticals Intl (VRX), Akorn (AKRX), Opko Health (OPK), Hikma Pharmaceuticals Plc (HIK), Horizon Pharma PLC (HZNP), Amicus Therapeutics (FOLD), Corcept Therapeutics Incorporated (CORT), Theravance Biopharma (TBPH), Cambrex Corporation (CBM), Emergent Biosolutions (EBS), Innoviva (INVA), Impax Laboratories (IPXL), Pacira Pharmaceuticals (PCRX), Akcea Therapeutics (AKCA) and Lannett Co (LCI).
Who are BTG plc's key executives?
BTG plc's management team includes the folowing people:
- Dame Pamela Louise Makin Ph.D., Chief Executive Officer, Executive Director
- Rolf B. Soderstrom, Chief Financial Officer, Executive Director
- Paul Mussenden, General Counsel, Head of Strategic Affairs, Company Secretary
- Garry Andrew Watts, Non-Executive Chairman of the Board
- Susan Elizabeth Foden Ph.D., Non-Executive Independent Director
- Graham Hetherington, Non-Executive Independent Director
- Giles Francis Bertram Kerr, Senior Independent Non-Executive Director
- Ian F. R. Much, Independent Non-Executive Director
How do I buy BTG plc stock?
Shares of BTG plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is BTG plc's stock price today?
MarketBeat Community Rating for BTG plc (LON BTG)MarketBeat's community ratings are surveys of what our community members think about BTG plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of BTG plc stock can currently be purchased for approximately GBX 740.
Consensus Ratings for BTG plc (LON:BTG) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||3 Hold Ratings, 6 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.67)|
|Consensus Price Target: ||GBX 780.33|Consensus Price Target History for BTG plc (LON:BTG)
Analysts' Ratings History for BTG plc (LON:BTG)
(Data available from 10/23/2015 forward)
|10/18/2017||Numis Securities Ltd||Reiterated Rating||Buy||GBX 900|
|10/13/2017||Deutsche Bank AG||Reiterated Rating||Buy||GBX 775|
|10/6/2017||J P Morgan Chase & Co||Reiterated Rating||Neutral|
|9/20/2017||Peel Hunt||Reiterated Rating||Hold||GBX 680|
|8/30/2017||Stifel Nicolaus||Reiterated Rating||Buy||GBX 800|
|7/13/2017||Shore Capital||Reiterated Rating||not rated|
|5/22/2017||Panmure Gordon||Lower Price Target||Buy||GBX 809 -> GBX 793|
|5/16/2017||Jefferies Group LLC||Reiterated Rating||Buy||GBX 775|
|4/6/2017||Investec||Reiterated Rating||Buy||GBX 720|
|11/1/2016||Royal Bank Of Canada||Downgrade||Sector Performer||GBX 910 -> GBX 790|
Earnings History for BTG plc (LON:BTG)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for BTG plc (LON:BTG)
Current Year EPS Consensus Estimate: $29.31 EPS
Dividend History for BTG plc (LON:BTG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for BTG plc (LON:BTG)Insider Trades by Quarter for BTG plc (LON:BTG)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/9/2017||Rolf Soderstrom||Insider||Sell||22,624||GBX 649||£146,829.76|
|6/1/2017||Rolf Soderstrom||Insider||Sell||129,514||GBX 655||£848,316.70|
|7/6/2016||Makin,Dame Pamela Louise||Insider||Sell||256,404||GBX 695||£1,782,007.80|
|6/3/2015||Rolf Soderstrom||Insider||Sell||35,225||GBX 704.88||£248,293.98|
Headline Trends for BTG plc (LON:BTG)
Latest Headlines for BTG plc (LON:BTG)
Loading headlines, please wait.
BTG plc (BTG) Chart for Monday, October, 23, 2017